Epidemiology, clinical pattern and impact of species-specific molecular diagnosis on management of leishmaniasis in Belgium, 2010–2018: A retrospective study
Open Access
- 22 September 2020
- journal article
- research article
- Published by Elsevier BV in Travel Medicine and Infectious Disease
- Vol. 38, 101885
- https://doi.org/10.1016/j.tmaid.2020.101885
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Cutaneous leishmaniasis in Switzerland: first experience with species-specific treatmentInfection, 2013
- Epidemiology of Imported Cutaneous Leishmaniasis at the Hospital for Tropical Diseases, London, United Kingdom: Use of Polymerase Chain Reaction to Identify the SpeciesThe American Journal of Tropical Medicine and Hygiene, 2012
- Leishmaniasis, an emerging infection in travelersInternational Journal of Infectious Diseases, 2010
- Mucosal leishmaniasis: Current scenario and prospects for treatmentActa Tropica, 2008
- Influence ofLeishmania (Viannia)Species on the Response to Antimonial Treatment in Patients with American Tegumentary LeishmaniasisThe Journal of Infectious Diseases, 2007
- Drug Resistance in LeishmaniasisClinical Microbiology Reviews, 2006
- Treatment of cutaneous leishmaniasis among travellersJournal of Antimicrobial Chemotherapy, 2004
- Fluconazole for the Treatment of Cutaneous Leishmaniasis Caused byLeishmania majorThe New England Journal of Medicine, 2002
- Epidemiology of American Cutaneous Leishmaniasis Due to Leishmania braziliensis brasiliensisThe Journal of Infectious Diseases, 1987
- Mucosal leishmaniasis (“spundia” Escomel, 1911)Transactions of the Royal Society of Tropical Medicine and Hygiene, 1986